In an era when Washington seems incapable of finding common ground on virtually any issue, it’s notable to encounter a policy area where stakeholders across the political spectrum agree. Gene ...
Scientists developed a light-responsive artificial nucleic acid that enables reversible, controllable crosslinking within DNA, opening doors for nanomedicine, DNA nanotechnologies and drug delivery.
SALT LAKE CITY, Nov. 7, 2025 /PRNewswire/ -- Resonant, a Renew Biotechnologies subsidiary developing novel diagnostic tools for neurodegenerative diseases, announces the receipt of "DNA Sequencing ...
Data confirms Versamune® HPV has potential as a broadly effective treatment of HPV16-associated cancers – Initiation of Phase 3 trial in HPV16-positive HNSCC planned for Q1 2025 Versamune® HPV + CRT ...
CORONA, Calif., Nov. 10, 2025 /PRNewswire/ -- The DNA Company, a global leader in functional genomics and personalized health, has been named Functional Genomics Innovation of the Year in the 2025 ...
STONY BROOK, NY / ACCESSWIRE / July 13, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it has acquired ...
The 2025 MM+M Agency 100 honoree debuted DNAHelix in a bid to help biotech companies develop a unified brand narrative and engage with key stakeholders as they grow. The launch of DNAHelix also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results